CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies - Wikidata - awgldk - TriplyDB

CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies

CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies

http://www.wikidata.org/entity/Q33743734

about

Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1 Induction of a Tier-1-like Phenotype in Diverse Tier-2 Isolates by Agents that Guide HIV-1 Env to Perturbation-sensitive, Non-native States.Binding mode characterization of NBD series CD4-mimetic HIV-1 entry inhibitors by X-ray structure and resistance study.Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation.CD4 mimetics sensitize HIV-1-infected cells to ADCC.Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors.The Yin and Yang of ADCC-Mediating Antibodies.Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry Inhibition.Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds.Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.Driving HIV-1 into a Vulnerable Corner by Taking Advantage of Viral Adaptation and Evolution.Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.Double Variational Binding--(SMILES) Conformational Analysis by Docking Mechanisms for Anti-HIV Pyrimidine Ligands.Uncovering HIV-1-infected cells.Comparison of Uncleaved and Mature Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimers.A Small-Molecule CD4-mimetic Compound Protects BLT Humanized Mice from Human Immunodeficiency Virus Infection.A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challenge.

P2860

Q26782237-BD5BA885-42FF-4DDC-9EB0-705519905EE8 Q30401836-4DF858EC-1791-4686-B1E9-B761AA016946 Q34057606-3C0CABC6-D6B7-4E44-93D3-2AA8978E04BD Q34594905-CF3975E2-5812-4E95-BF87-65BEC6965E35 Q34801630-7AE8B0F7-CA2E-4A4C-BC72-41FCDA6DD97E Q35644696-A542E169-C69B-473E-830B-CB779C46EB26 Q35927570-A8B424E1-BC04-4DDB-A27A-69BA2DDAAC5F Q36538736-E94AEF5F-4DE3-49CA-8118-D76558899DAE Q36538762-13128A3B-DFCE-4F33-B031-D391F943843D Q36681727-75B0FB45-D846-4867-8081-FCFFDB335333 Q36878885-0A990DB7-2A56-4202-A001-BA804213CB59 Q37593189-BE20E017-B74B-4DC9-8983-E0B1C22E379B Q37703084-CCF534E2-14C9-4814-9A04-CCA81B8DE615 Q40399853-9709BB2B-5143-431A-BD90-B870B42B80CB Q41040182-4AD85E3C-BF91-4279-8501-238DECD232C9 Q42876801-C1AE9DFC-182E-4947-B8C1-6378222CDDD7 Q52721542-70150B26-4DCD-412C-AA1E-9BABC6F119C3 Q53075666-8111BEC8-AF5D-429A-B079-24562B941351 Q55383445-42409CE1-6FAB-4793-A5B8-3645883FBBC4

P2860

CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies

http://www.wikidata.org/entity/Q33743734

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

CD4-mimetic small molecules se ...... to vaccine-elicited antibodies

@ast

CD4-mimetic small molecules se ...... to vaccine-elicited antibodies

@en

type

label

CD4-mimetic small molecules se ...... to vaccine-elicited antibodies

@ast

CD4-mimetic small molecules se ...... to vaccine-elicited antibodies

@en

prefLabel

CD4-mimetic small molecules se ...... to vaccine-elicited antibodies

@ast

CD4-mimetic small molecules se ...... to vaccine-elicited antibodies

@en

P1433

Q33743734-F4F38A81-004E-4650-B4F5-F7D950A7E9C6

P1476

Q33743734-F430C51B-4762-4389-BD1F-2E6E66013F4D

P2093

Q33743734-033A5132-60FC-4C65-A074-0559483FC274

Q33743734-05CBF443-3D1E-4C0F-A29F-896A246806D3

Q33743734-1F4D779E-C12E-472C-B21A-1A72AB3E82E6

Q33743734-2185884E-26EE-4223-9318-E7818979C7DC

Q33743734-43C3FF65-7F76-4E2C-A847-252779BD1598

Q33743734-570B7E20-9852-4191-AC2A-EEA1BF7039B1

Q33743734-60B888D6-9501-4041-81D5-93809241E3A3

Q33743734-6A4B28F3-29BC-4C07-9413-C7CBD234BB8C

Q33743734-712CF352-6D45-4FC5-8893-C0DBCFE5B77E

Q33743734-71C869EF-88F0-4A63-B24C-AC139DDFCC88

P2860

Q33743734-0274DC58-AA62-4EF3-9A13-74C38C0D55BA

Q33743734-033DA36C-1123-42D5-A1F5-C168B7C52B4D

Q33743734-035CF998-9C01-4924-A0DD-6B711199D751

Q33743734-03C00ABE-E642-4EAF-A2CD-DD27A1BCE7F1

Q33743734-06743EA9-1D02-4BB0-8932-3317E3E5F065

Q33743734-09DFE872-AB72-4E0B-8E34-DB680DBAA64B

Q33743734-0FAE748B-800C-4669-956C-F632594A3DB7

Q33743734-12BCA5D3-DF6C-48FA-8880-25BB9575262B

Q33743734-20D2ABDC-4883-4DDE-BA49-1CE8EFCA09D6

Q33743734-21CEEBD3-DB3F-44C8-9893-0B5218ACD121

P304

Q33743734-3199530A-2558-4130-9463-E1F7EFE0A58D

P31

Q33743734-A3B612E9-DB6A-4EBB-A5A5-A770E5240FD4

P356

Q33743734-6A8D74F0-12CA-41E6-AFA3-BA4960DAA385

P433

Q33743734-533271E1-CA0B-4235-B5BC-5A738186E5AB

P478

Q33743734-4E330DC9-8397-41C0-A69D-4CA4DD2C0578

P50

Q33743734-CCDF9508-67BA-48CA-9B75-EA40757C8F54

Q33743734-ED425837-DC22-4B48-8072-6979DD11254E

P577

Q33743734-EE691B21-7AC0-4BD5-970A-BC7D8F202FC4

P5875

Q33743734-BB69A4C0-4747-467A-A701-7869EB6E0747

P698

Q33743734-0D24AEB1-6FAA-4E1F-8B0B-5E5BC7F52B7F

P932

Q33743734-E80AD08A-7042-4ADD-8C65-85131AE08B7B

P356

P1433

Journal of Virology

P1476

CD4-mimetic small molecules se ...... to vaccine-elicited antibodies

@en

P2093

Amos B Smith

http://www.w3.org/2001/XMLSchema#string

Amy M Princiotto

http://www.w3.org/2001/XMLSchema#string

Arne Schön

http://www.w3.org/2001/XMLSchema#string

David M Jones

http://www.w3.org/2001/XMLSchema#string

Ernesto Freire

http://www.w3.org/2001/XMLSchema#string

Hua-Xin Liao

http://www.w3.org/2001/XMLSchema#string

James Robinson

http://www.w3.org/2001/XMLSchema#string

Joel R Courter

http://www.w3.org/2001/XMLSchema#string

Jongwoo Park

http://www.w3.org/2001/XMLSchema#string

Judith LaLonde

http://www.w3.org/2001/XMLSchema#string

P2860

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Identification of a major co-receptor for primary isolates of HIV-1

Energetics of the HIV gp120-CD4 binding reaction

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1

A Blueprint for HIV Vaccine Discovery

Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

P304

6542-6555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00540-14

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Joseph Sodroski

P577

2014-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261328806

http://www.w3.org/2001/XMLSchema#string

P698

24696475

http://www.w3.org/2001/XMLSchema#string

P932

4054336

http://www.w3.org/2001/XMLSchema#string